X4 Pharmaceuticals Inc. (XFOR)
NASDAQ · Healthcare
X4 Pharmaceuticals Inc. Operating Income 2018–2025
X4 Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- X4 Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -20.3 M, a 115.04% increase year-over-year.
- X4 Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -83.5 M, a 199.25% increase year-over-year.
- X4 Pharmaceuticals Inc. annual operating income for 2025 was -86.9 M, a 138.68% increase from 2024.
- X4 Pharmaceuticals Inc. annual operating income for 2024 was -36.4 M, a 66.15% decrease from 2023.
- X4 Pharmaceuticals Inc. annual operating income for 2023 was -107.5 M, a 22.79% increase from 2022.
- X4 Pharmaceuticals Inc. annual operating income for 2022 was -87.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
X4 Pharmaceuticals Inc. Operating Income — FAQ
X4 Pharmaceuticals Inc. (XFOR) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is X4 Pharmaceuticals Inc.'s operating income?
X4 Pharmaceuticals Inc. (XFOR) reported operating income of -$87M for fiscal 2025.
Where can I see XFOR's operating income history?
The chart and table above show X4 Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.